Pyxis Oncology, Inc. (PYXS) stock
PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.44+0.03 (+2.13%)
Close on Nov 17, 2026Market cap $120.11MP/E –Yield –
Pyxis Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pyxis Oncology's enterprise value was $71.03M on Nov 11, 2026, against $246.26M a year earlier. Over the last 5 years it ranged from -$195.79M to $246.26M, with a median of -$36.37M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $71.03M | – |
| 2025 | Dec 31, 2025 | -$4.83M | – |
| 2024 | Dec 31, 2024 | -$52.06M | – |
| 2023 | Dec 29, 2023 | -$53.27M | – |
| 2022 | Dec 30, 2022 | -$154.87M | – |
| 2021 | Dec 31, 2021 | -$115.49M | – |
See a number that looks wrong?